2021

COVID-19 is a dangerous respiratory infection, which can lead to severe complications. One of such complications is heart damage. Scientists at UCL found that more than 50% of patients hospitalised with COVID-19, who had raised levels of a protein called troponin, have some heart damage. Having in mind that troponin […]

As people age, a normal brain protein is known as amyloid-beta often starts to collect into harmful amyloid plaques in the brain. Such plaques can be the first step on the path to Alzheimer’s dementia. When they form around blood vessels in the brain, a condition known as cerebral amyloid […]

Location of blockages in a patient’s heart is a key consideration in selecting the right treatment, U of A cardiologists find. A new study by University of Alberta cardiologists at the Canadian VIGOUR Centre shows that a particular group of patients with stable ischemic heart disease have better outcomes with the […]

The pancreas is one of the most important organs in the body. It produces insulin to regulate blood sugar and helps digest food. If the pancreas goes haywire, diabetes, cancer, or other diseases threaten lives. Yet, a lot remains unknown about how the pancreas keeps people healthy and how the […]

If all goes as envisioned, research done at the UO could one day lead to a blood test to guide treatment for trauma victims whose bones may be slow to heal. A team led by Robert Guldberg of the UO’s Phil and Penny Knight Campus for Accelerating Scientific Impact reported […]

In a milestone for biomolecular design, a team of scientists has succeeded in creating new proteins that adopt one of the most complex folds known to molecular biology. These designer proteins were shown in the lab to spontaneously fold into their intended structures and embed into lipid membranes. As reported […]

Vanderbilt biochemist Yi Ren is part of a team that has identified a new behaviour of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. The article, “Nsp1 Protein of SARS-CoV-2 Disrupts […]

Research led by McGill University and Queen’s University Belfast has found that viruses can ‘hijack’ an existing molecular process in the cell in order to block the body’s antiviral immune response to a viral infection. The results of the study have been published in the journal Molecular Cell. As the current […]

The Physics for Medicine Paris laboratory (Inserm/ESPCI Paris-PSL/CNRS), in collaboration with Robert Debré Hospital (AP-HP/Inserm) is developing functional ultrasound imaging to monitor the brain activity of neonates in a way that existing neuroimaging modalities do not achieve. Their latest study, published in Nature Communications, marks another leap forward by demonstrating […]

Findings involving antibody effector functions could help improve design of next-generation COVID-19 antibody drugs. Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made antibodies that neutralize the […]

With a San Francisco biotech company, an UdeM eye expert develops a treatment that could potentially treat patients who suffer from this degenerative disease of the retina. Potentially effective treatment for diabetic retinopathy, a disease that swells and scars the retina, has been developed by an Université de Montréal scientist […]

In the ongoing battle to find ways to treat cancer, a team at the University of Missouri is addressing the problem from multiple angles, but with a precision approach. Cancer patients are often given chemotherapy, cancer-fighting drugs that kill cancerous cells and can also have harsh effects on healthy cells. […]